Viridien
Short position disclosed on September 22, 2026.
8.39% of the capital sold short
9 disclosing funds
2,491 disclosures on record
Evolution of the disclosed total
0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Capital Fund Management | 1.52% | +0.95 pt | September 15, 2026 | ||
| Marshall Wace LLP | 1.40% | -0.11 pt | September 22, 2026 | ||
| Citadel Advisors LLC | 1.12% | +0.34 pt | September 21, 2026 | ||
| Worldquant, LLC | 1.03% | new | September 22, 2026 | ||
| Walleye Capital LLC | 0.71% | new | August 17, 2026 | AMF | |
| TWO Sigma Investments, LP | 0.70% | new | August 19, 2026 | AMF | |
| Tudor Capital Europe LLP | 0.70% | new | September 21, 2026 | ||
| Acadian Asset Management LLC | 0.64% | new | September 22, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 7,682 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| June 10, 2024 | Qube Research & Technologies Limited | 1.59% | January 23, 2025 | |
| June 5, 2024 | Qube Research & Technologies Limited | 1.65% | January 23, 2025 | |
| June 3, 2024 | Qube Research & Technologies Limited | 1.52% | January 23, 2025 | |
| June 3, 2024 | Marshall Wace LLP | 1.21% | March 24, 2025 | |
| May 31, 2024 | Qube Research & Technologies Limited | 1.42% | January 23, 2025 | |
| May 30, 2024 | Qube Research & Technologies Limited | 1.36% | January 23, 2025 | |
| May 29, 2024 | Qube Research & Technologies Limited | 1.27% | January 23, 2025 | |
| May 28, 2024 | Marshall Wace LLP | 1.19% | March 24, 2025 | |
| May 28, 2024 | Qube Research & Technologies Limited | 1.05% | January 23, 2025 | |
| May 27, 2024 | Marshall Wace LLP | 1.28% | March 24, 2025 | |
| May 27, 2024 | Qube Research & Technologies Limited | 0.84% | January 23, 2025 | |
| May 23, 2024 | Marshall Wace LLP | 1.39% | March 24, 2025 | |
| May 20, 2024 | Marshall Wace LLP | 1.49% | March 24, 2025 | |
| May 17, 2024 | Marshall Wace LLP | 1.53% | March 24, 2025 | |
| May 17, 2024 | Qube Research & Technologies Limited | 0.71% | January 23, 2025 | |
| May 16, 2024 | Marshall Wace LLP | 1.64% | March 24, 2025 | |
| May 16, 2024 | Qube Research & Technologies Limited | 0.63% | January 23, 2025 | |
| May 15, 2024 | Marshall Wace LLP | 1.73% | March 24, 2025 | |
| May 15, 2024 | Qube Research & Technologies Limited | 0.50% | January 23, 2025 | |
| May 8, 2024 | Marshall Wace LLP | 2.03% | March 24, 2025 | |
| May 7, 2024 | Citadel Securities (Europe) Limited | 0.47% | May 9, 2024 | |
| May 6, 2024 | Marshall Wace LLP | 1.90% | March 24, 2025 | |
| May 6, 2024 | Citadel Securities (Europe) Limited | 0.50% | May 9, 2024 | |
| May 3, 2024 | Citadel Securities (Europe) Limited | 0.49% | May 7, 2024 | |
| May 2, 2024 | Citadel Securities (Europe) Limited | 0.50% | May 7, 2024 | |
| April 15, 2024 | Marshall Wace LLP | 1.81% | March 24, 2025 | |
| April 12, 2024 | Marshall Wace LLP | 1.91% | March 24, 2025 | |
| April 11, 2024 | Marshall Wace LLP | 2.08% | March 24, 2025 | |
| April 10, 2024 | Citadel Advisors LLC | 0.35% | April 12, 2024 | |
| April 9, 2024 | Marshall Wace LLP | 2.34% | March 24, 2025 | |
| April 9, 2024 | Citadel Advisors LLC | 0.58% | April 12, 2024 | |
| April 8, 2024 | Marshall Wace LLP | 2.26% | March 24, 2025 | |
| April 8, 2024 | Citadel Advisors LLC | 0.68% | April 12, 2024 | |
| April 5, 2024 | Marshall Wace LLP | 2.13% | March 24, 2025 | |
| April 4, 2024 | Citadel Advisors LLC | 0.82% | April 12, 2024 | |
| April 3, 2024 | Marshall Wace LLP | 2.02% | March 24, 2025 | |
| April 2, 2024 | Marshall Wace LLP | 1.90% | March 24, 2025 | |
| March 28, 2024 | Marshall Wace LLP | 1.82% | March 24, 2025 | |
| March 28, 2024 | Citadel Advisors LLC | 0.79% | April 12, 2024 | |
| March 26, 2024 | Citadel Advisors LLC | 0.82% | April 12, 2024 | |
| March 26, 2024 | Systematica Investments Limited | 0.49% | March 28, 2024 | |
| March 25, 2024 | Citadel Advisors LLC | 0.77% | April 12, 2024 | |
| March 22, 2024 | Systematica Investments Limited | 0.56% | March 28, 2024 | |
| March 19, 2024 | Marshall Wace LLP | 1.79% | March 24, 2025 | |
| March 19, 2024 | Citadel Advisors LLC | 0.83% | April 12, 2024 | |
| March 18, 2024 | Marshall Wace LLP | 1.86% | March 24, 2025 | |
| March 18, 2024 | Citadel Advisors LLC | 0.43% | March 20, 2024 | |
| March 13, 2024 | Citadel Advisors LLC | 0.57% | March 20, 2024 | |
| March 8, 2024 | Marshall Wace LLP | 1.79% | March 24, 2025 | |
| March 8, 2024 | Citadel Advisors LLC | 0.62% | March 20, 2024 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 2491 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.35% of the capital sold short
- Valeo 11.29% of the capital sold short
- Renault 9.50% of the capital sold short
- Teleperformance 6.31% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Abivax 4.47% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- DBV Technologies 4.21% of the capital sold short
- VusionGroup 3.91% of the capital sold short
- Sopra Steria Group 3.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at September 22, 2026, https://www.quivad.com/action/viridien?page=8